Back to Agenda
FDA Townhall
Session Chair(s)
Katherine Tyner, PHD
Senior Director, Regulatory Policy Leader EMEA & CMC, Johnson & Johnson, Netherlands
FDA maintains a global presence to facilitate collaborations amongst regulators and speed the development of critical medical products. In Europe, FDA uses multiple platforms and mechanisms to collaborate on a wide range of activities from technical exchange, to reliance on GMP inspections, to discussions of emerging and innovative technologies. In this session, you will hear about current FDA activities and priorities for the coming years.?
Speaker(s)
Katherine Marie Serrano
Director, Europe Office, Office of Global Policy and Strategy, FDA, United States
FDA in Your Neighborhood: Overview of the FDA Europe Office
Shannon Thor, PHARMD, MS
FDA Liaison to the European Medicines Agency, FDA, United States
FDA Europe Office Priorities 2024
Katherine Tyner, PHD
Senior Director, Regulatory Policy Leader EMEA & CMC, Johnson & Johnson, Netherlands
FDA – EMA Collaborations
Ioana Ulea, LLM
Senior Policy Advisor, FDA, Belgium
Moderator
Have an account?